Eculizumab's Unintentional Mayhem: A Systematic Review

Eculizumab, first-line therapy for paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), has infectious side effects in addition to its therapeutic benefits. This study aims to discuss the mechanism of development of infections, prevention, and timely treatment to...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhanoa, Ravneet K, Selvaraj, Ramaneshwar, Shoukrie, Shoukrie I, Zahra, Anam, Malla, Jyothirmai, Selvamani, Tharun Yadhav, Venugopal, Sathish, Hamouda, Ranim K, Hamid, Pousette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249032/
https://www.ncbi.nlm.nih.gov/pubmed/35784997
http://dx.doi.org/10.7759/cureus.25640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249032/
https://www.ncbi.nlm.nih.gov/pubmed/35784997
http://dx.doi.org/10.7759/cureus.25640

Ejemplares similares